KOL Event: Novel InhiBET BET Inhibitor Platform Post date May 17, 2022 Post categories In Presentations KOL Event – Novel InhiBET BET Inhibitor Platform Post navigation ←Previous post:SEC Filing: Form 8-K→Next post:SEC Filing: Form 4
VYNE Therapeutics
VYNE Therapeutics